Fig. 6From: Pharmacotechnical aspects of a stable probiotic formulation toward multidrug-resistance antibacterial activity: design and quality controlThe viability percentage of MRSA and VRE treated by the F4 formulation, formulation gel, probiotic precipitate, Vancomycin, and Methicillin in different concentrationsBack to article page